Sanofi India Limited Teicoplanin Export Data — India (DGFT 2022–2026)

Name: Sanofi India Limited Teicoplanin Export Records India — #7 Exporter, 6 Shipments, $101.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Teicoplanin

India Pharmaceutical Trade Intelligence

$6.3M60 Suppliers44 CountriesHS 30042099

ExportsIndia → HUNGARY35.6%India → SRI LANKA18.4%

ImportsITALY → India$65.9B FRANCE → India$517.3K

#1 Supplier: GUFIC BIOSCIENCES

Sanofi India Limited — Teicoplanin Exporter #7 | $101.2K Trade Value | TransData Nexus | TransData Nexus

Sanofi India Limited — Teicoplanin Exporter Profile

Indian Pharmaceutical Exporter · #7 for Teicoplanin · $101.2K export value · DGFT Verified

Sanofi India Limited is the #7 Indian exporter of Teicoplanin with $101.2K in export value and 6 verified shipments. Sanofi India Limited holds a 1.6% market share in Teicoplanin exports across 1 countries. The company exports 4 pharmaceutical products worth $9.0M across 4 therapeutic categories.

Sanofi India Limited — Teicoplanin Export Profile: Buyers & Destinations

Sanofi India Limited Teicoplanin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Teicoplanin?

Country	Value	Shipments	Share
SRI LANKA	$1.2M	43	24.1%
HUNGARY	$1.1M	23	24.0%
SOUTH AFRICA	$1.1M	21	21.9%
GERMANY	$336.9K	7	7.0%

Who Are the Top Buyers of Teicoplanin from India?

Buyer	Country	Value	Orders
SLIM PHARMACEUTICALS (PVT) LTD,	SRI LANKA	$245.7K	14
YADEN INTERNATIONAL (PVT) LTD	SRI LANKA	$215.1K	5
MEDPRO PHARMACEUTICA PTY LTD	SOUTH AFRICA	$209.1K	6
AUSTELL PHARMACEUTICALS (PTY) LTD,	SOUTH AFRICA	$195.1K	4
AUSTELL PHARMACEUTICALS ( PTY) LTD	SOUTH AFRICA	$150.0K	3
HANSE SERVICE INTERNATIONALE	GERMANY	$150.0K	3
MEDICUBA, S.A.	CUBA	$100.0K	2
PEOPLE'S BANK,	SRI LANKA	$100.0K	2
AUSTELL PHARMACEUTICALS ( PTY) LIMITED	SOUTH AFRICA	$100.0K	2
M/S. OOO JODAS EXPOIM..	RUSSIA	$100.0K	2

India's Teicoplanin is purchased by 108 buyers worldwide. The top buyer is SLIM PHARMACEUTICALS (PVT) LTD, (SRI LANKA), followed by YADEN INTERNATIONAL (PVT) LTD and MEDPRO PHARMACEUTICA PTY LTD.

How Does Sanofi India Limited Compare to Nearest Teicoplanin Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	NEON LABORATORIES LIMITED	$215.1K	6	2	$35.8K
6	VENUS REMEDIES LIMITED	$134.1K	18	9	$7.4K
7	SANOFI INDIA LIMITED ★	$101.2K	6	1	$16.9K
8	UNITED BIOTECH PRIVATE LIMITED	$91.2K	19	8	$4.8K
9	CELON LABORATORIES PRIVATE LIMITED	$82.4K	6	1	$13.7K

Sanofi India Limited ranks #7 among 60 Indian Teicoplanin exporters. Average shipment value of $16.9K compared to the market average of $95.7K. The closest competitors by value are NEON LABORATORIES LIMITED and VENUS REMEDIES LIMITED.

Which Indian Ports Ship Teicoplanin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	69	22.3%
SAHAR AIR	67	21.6%
NHAVA SHEVA SEA (INNSA1)	27	8.7%
DELHI AIR	24	7.7%
Bombay Air	22	7.1%
DELHI AIR CARGO ACC (INDEL4)	16	5.2%
CHENNAI AIR CARGO ACC (INMAA4)	8	2.6%
HYDERABAD AIR	8	2.6%

Geopolitical & Trade Policy Impact on Sanofi India Limited's Teicoplanin Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Sanofi India. The escalation of conflicts in the Middle East, particularly around the Red Sea and Suez Canal, has disrupted key shipping routes. Major carriers have suspended or restricted transits, leading to extended transit times by 10–20 days and increased freight rates by 40–50% on India–Europe routes. (livemint.com) These disruptions pose risks to the timely delivery of temperature-sensitive pharmaceuticals, potentially affecting product efficacy and market competitiveness.

In the United States, the implementation of tariffs on pharmaceutical imports, including a 25% reciprocal tariff and an additional 25% penalty tied to India's energy policies, has created an uncertain trade environment. Although pharmaceuticals have been exempt from some of these tariffs, the potential for future escalations remains a concern. (en.wikipedia.org) Additionally, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures, adding complexity to market entry and sustainability for exporters like Sanofi India.

Sanofi India Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Sanofi India has consistently adhered to guidelines set by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). This commitment ensures product quality and facilitates access to global markets. However, evolving regulatory requirements, such as the EU's Falsified Medicines Directive, demand continuous adaptation and investment in compliance infrastructure. For instance, the directive's serialization and traceability mandates require significant technological upgrades, impacting operational costs and necessitating strategic planning.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Teicoplanin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Sanofi India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 44+ countries, 108+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Teicoplanin

Teicoplanin

Sanofi India Limited — Teicoplanin Exporter Profile

Sanofi India Limited — Teicoplanin Export Profile: Buyers & Destinations

Where Does India Export Teicoplanin?

Who Are the Top Buyers of Teicoplanin from India?

What Is India's Total Teicoplanin Export Value and How Much Does Sanofi India Limited Contribute?

What Is the Average Shipment Value for Sanofi India Limited's Teicoplanin Exports?

How Does Sanofi India Limited Compare to Other Indian Teicoplanin Exporters?

Regulatory Requirements: Exporting Teicoplanin to Key Markets

South Africa — SAHPRA

Germany — BfArM/EMA

How Does Sanofi India Limited Compare to Nearest Teicoplanin Exporters?

Which Indian Ports Ship Teicoplanin Exports?

Geopolitical & Trade Policy Impact on Sanofi India Limited's Teicoplanin Exports

Sanofi India Limited — Regulatory Compliance & Quality Standards

About Sanofi India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Teicoplanin Export Data from Sanofi India Limited

Teicoplanin Stats

Company Overview

Top Products by Sanofi India Limited

Related Analysis

Need Detailed Export Data?

Data Source